Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6

Molecular and Cellular Biology

Volumn 24, Issue 15, 2004, Pages 6560-6568

  Ogasawara, Toru ^a   Kawaguchi, Hiroshi ^a   Jinno, Shigeki ^a   Hoshi, Kazuto ^a   Itaka, Keiji ^a   Takato, Tsuyoshi ^a   Nakamura, Kozo ^a   Okayama, Hiroto ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CYCLIN DEPENDENT KINASE 6; SMAD PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; BROMODEOXYURIDINE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CHROMATIN; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; DOWN-REGULATION; FLOW CYTOMETRY; G1 PHASE; MICE; MODELS, BIOLOGICAL; OSTEOBLASTS; PRECIPITIN TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 3242711209     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.15.6560-6568.2004     Document Type: Article

References (33)

1. Bai, S., X. Shi, X. Yang, and X. Cao. 2000. Smad6 as a transcriptional corepressor. J. Biol. Chem. 275:8267-8270.
2. Chen, Q., J. Lin, S. Jinno, and H. Okayama. 2003. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 22:992-1001.
3. Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
4. DiChiara, M. R., J. M. Kiely, M. A. Gimbrone, Jr., M. E. Lee, M. A. Perrella, and J. N. Topper. 2000. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J. Exp. Med. 192:695-704.
5. Hinds, P. W., and R. A. Weinberg. 1994. Tumor suppressor genes. Curr. Opin. Genet. Dev. 4:135-141.
6. Kretzschmar, M., and J. Massague. 1998. SMADs: mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 8:103-111.
7. Lee, K. S., H. J. Kim, Q. L. Li, X. Z. Chi, C. Ueta, T. Komori, J. M. Wozney, E. G. Kim, J. Y. Choi, H. M. Ryoo, and S. C. Bae. 2000. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 20:8783-8792.
8. Lin, J., S. Jinno, and H. Okayama. 2001. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence. Oncogene 20:2000-2009.
9. Lopez-Rovira, T., E. Chalaux, J. L. Rosa, R. Bartrons, and F. Ventura. 2000. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the JunB promoter. J. Biol. Chem. 275:28937-28946.
10. Matushansky, I., F. Radparvar, and A. I. Skoultchi. 2003. CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells. Oncogene 22:4143-4149.
11. Meyerson, M., G. H. Enders, C. L. Wu, L. K. Su, C. Gorka, C. Nelson, E. Harlow, and L. H. Tsai. 1992. A family of human cdc2-related protein kinases. EMBO J. 11:2909-2917.
12. Nakashima, K., X. Zhou, G. Kunkel, Z. Zhang, J. M. Deng, R. R. Behringer, and B. de Crombrugghe. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
13. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, and D. Y. Loh. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
14. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
15. Nishimori, S., Y. Tanaka, T. Chiba, M. Fujii, T. Imamura, K. Miyazono, T. Ogasawara, H. Kawaguchi, T. Igarashi, T. Fujita, K. Tanaka, and H. Toyoshima. 2001. Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in osteoblastic cells. J. Biol. Chem. 276:10700-10705.
16. Patel, M. S., and G. Karsenty. 2002. Regulation of bone formation and vision by LRP5. N. Engl. J. Med. 346:1572-1574.
17. Reddi, A. H. 1998. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol. 16:247-252.
18. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
19. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
20. Shi, X., X. Yang, D. Chen, Z. Chang, and X. Cao. 1999. Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J. Biol. Chem. 274:13711-13717.
21. Takeda, K., H. Ichijo, M. Fujii, Y. Mochida, M. Saitoh, H. Nishitoh, T. K. Sampath, and K. Miyazono. 1998. Identification of a novel bone morphogenetic protein-responsive gene that may function as a noncoding RNA. J. Biol. Chem. 273:17079-17085.
22. Tanaka, K., and H. Okayama. 2000. A Pcl-like cyclin activates the Res2p-Cdc10p cell cycle "start" transcriptional factor complex in fission yeast. Mol. Biol. Cell 11:2845-2862.
23. Thomas, D. M., S. A. Carty, D. M. Piscopo, J. S. Lee, W. F. Wang, W. C. Forrester, and P. W. Hinds. 2001. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell 8:303-316.
24. Urano, T., H. Yashiroda, M. Muraoka, K. Tanaka, T. Hosoi, S. Inoue, Y. Ouchi, and H. Toyoshima. 1999. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. J. Biol. Chem. 274:12197-12200.
25. Verschueren, K., J. E. Remacle, C. Collart, H. Kraft, B. S. Baker, P. Tylzanowski, L. Nelles, G. Wuytens, M. T. Su, R. Bodmer, J. C. Smith, and D. Huylebroeck. 1999. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J. Biol. Chem. 274:20489-20498.
26. Vidal, A., and A. Koff. 2000. Cell-cycle inhibitors: three families united by a common cause. Gene 247:1-15.
27. Wang, H., T. Goode, P. Iakovo, J. H. Albrecht, and N. A. Timchenko. 2002. C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest. EMBO J. 21:930-941.
28. Yan, Y., J. Frisen, M. H. Lee, J. Massague, and M. Barbacid. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973-983.
29. Yoshida, Y., S. Tanaka, H. Umemori, O. Minowa, M. Usui, N. Ikematsu, E. Hosoda, T. Imamura, J. Kuno, T. Yamashita, K. Miyazono, M. Noda, T. Noda, and T. Yamamoto. 2000. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103:1085-1097.
30. Zhang, P., N. J. Liegeois, C. Wong, M. Finegold, H. Hou, J. C. Thompson, A. Silverman, J. W. Harper, R. A. DePinho, and S. J. Elledge. 1997. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.
31. Zhang, Y. W., N. Yasui, K. Ito, G. Huang, M. Fujii, J. Hanai, H. Nogami, T. Ochi, K. Miyazono, and Y. Ito. 2000. A RUNX2/PEBP2alphaA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA 97:10549-10554.
32. Zhu, H., P. Kavsak, S. Abdollah, J. L. Wrana, and G. H. Thomsen. 1999. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400:687-693.
33. Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.BM